Vertex (VRTX) insider Edward Atkinson files to sell 2,031 shares

Rhea-AI Filing Summary

Vertex Pharmaceuticals executive Edward Atkinson has filed a notice of proposed share sales under Rule 144. The filing covers the planned sale of 2,031 shares of Vertex common stock through Fidelity Brokerage Services LLC on or about 02/17/2026 on NASDAQ, with an aggregate market value of 994093.26 at the time of the notice.

The 2,031 shares to be sold were acquired on 02/13/2026 via restricted stock vesting from the issuer as compensation. Over the past three months, Atkinson has already sold 2,500 Vertex common shares on 11/17/2025 for gross proceeds of 1086450.00, and 1,751 shares on 02/11/2026 for gross proceeds of 806212.93. The filing also notes that the seller represents not being aware of undisclosed material adverse information about the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2031	994093.26	254034190	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			2031	02/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Edward Atkinson 50 Northern Avenue Boston MA 02210	Common	11/17/2025	2500	1086450.00
Edward Atkinson 50 Northern Avenue Boston MA 02210	Common	02/11/2026	1751	806212.93

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VRTX Form 144 filing by Edward Atkinson disclose?

The Form 144 discloses that Edward Atkinson intends to sell 2,031 shares of Vertex Pharmaceuticals common stock. The planned sale is under Rule 144, based on recently vested restricted stock received as compensation, and is scheduled to occur on or about February 17, 2026 on NASDAQ.

How many VRTX shares are proposed to be sold and at what market value?

The filing covers a proposed sale of 2,031 Vertex common shares with an aggregate market value of $994,093.26. This value reflects the market pricing at the time of the notice and is used for disclosure purposes rather than a guaranteed sale price.

How did Edward Atkinson acquire the VRTX shares he plans to sell?

The 2,031 Vertex shares to be sold were acquired on February 13, 2026 through restricted stock vesting. The filing states the shares came directly from the issuer as compensation, rather than an open-market purchase or gift, and were paid as part of Atkinson’s compensation.

Which broker and exchange are involved in the planned VRTX share sale?

The planned sale will be executed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The Form 144 specifies that the transaction is expected to take place on the NASDAQ exchange, where Vertex Pharmaceuticals common stock is listed and traded.

What VRTX stock sales has Edward Atkinson made in the past three months?

The filing reports two Vertex common stock sales in the prior three months. On November 17, 2025, Atkinson sold 2,500 shares for gross proceeds of $1,086,450. On February 11, 2026, he sold 1,751 shares for gross proceeds of $806,212.93.

Does the VRTX Form 144 include any representation about inside information?

Yes. The person for whose account the Vertex securities are to be sold represents that they do not know of any material adverse, nonpublic information about the issuer. This representation is part of the standard attestation language included with the Form 144 notice.